Finance Series 01 Feb 2019 When Shareholders Disagree: Trading After Shareholder Meetings Sophia Zhengzi Li Ernst Maug Miriam Schwartz-Ziv Trading Voting
Finance Series 01 Mar 2019 Shadow Pills, Visible Pill Policy, and Firm Value Martijn Cremers Lubomir Litov Simone Sepe And more (...) Poison Pill Takeovers Value
Finance Series 01 Mar 2019 Activism Pressure and the Market for Corporate Assets Ulrich Hege Yifei Zhang Activism Hedge Funds M&A Value
Finance Series 01 Mar 2019 Does Diversification of Share Classes Increase Firm Value? Sojung Kim Sunwoo Hwang Woochan Kim Dual Class Shares Shareholder Rights Shareholder Value Value
Finance Series 01 Mar 2019 Firms’ Rationales for CEO Duality: Evidence from a Mandatory Disclosure Regulation Marc Goergen Peter Limbach Meik Scholz-Daneshgari Boards CEO Regulation Reporting
Law Series 16 Feb 2019 Farewell to Fairness: Towards Retiring Delaware's Entire Fairness Review Amir Licht Fiduciary Duty Regulation
Law Series 12 Mar 2019 Which Related Party Transactions Should Be Subject to Ex Ante Review? Evidence from Germany Andreas Engert Tim Florstedt Company Law Corporate Groups Related Party Transactions Reporting
Law Series 12 Mar 2019 A Sustainable Platform Economy & the Future of Corporate Governance Mark Fenwick Erik Vermeulen ESG Technology
Finance Series 13 Mar 2019 The Intangibles Song in Takeover Announcements: Good Tempo, Hollow Tune Zoran M. Filipovic Alexander Wagner M&A Performance Value
Finance Series 13 Mar 2019 Survival and Conglomerate Value Michela Altieri Giovanna Nicodano Bankruptcy Value
Finance Series 13 Mar 2019 Picking Friends Before Picking (Proxy) Fights: How Mutual Fund Voting Shapes Proxy Contests Alon Brav Wei Jiang Tao Li And more (...) Funds Voting
